Identification of new aqueous chemical degradation products of isophosphoramide mustard

被引:6
作者
Breil, S
Martino, R
Gilard, V
Malet-Martino, M
Niemeyer, U
机构
[1] Univ Toulouse 3, Lab IMRCP, Grp RMN Biomed, F-31062 Toulouse, France
[2] ASTA Med AG, D-60314 Frankfurt, Germany
关键词
isophosphoramide mustard; P-31; NMR; hydrolysis compounds;
D O I
10.1016/S0731-7085(00)00582-3
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
NMR ((31)p, H-1 and C-13) spectroscopy was used to study the products of the degradation of isophosphoramide mustard (IPM) in buffered solutions at pH ranging from 1 to 13. At pH Il, the only degradation compounds detected were phosphate ion (Pi) and chloroethylammonium chloride (CEA-HCl), resulting from the breakdown of the two P-N bonds (Pathway Ia). At pH 9.3 and 13, only the products of 1,3-cyclization of the N-chloroethyl group (monoaziridinylIPM (monoAzIPM) and a very low level of bisaziridinylIPM (bisAzIPM)) were found after approximate to 15 h of reaction (pathway II). At intermediate pH, the two pathways coexist. At pH 3.5 and 5.0, the P-N bond hydrolysis is the major pathway, but two final phosphorylated products were detected, Pi which represented 67% (pH 3.5) and 17% (pH 5.0) of all the IPM phosphorylated degradation products after approximate to 15 h of reaction, and phosphorylethanolamine (PEA) which represented 16% (pH 3.5) and 46% (pH 5.0) of the same sum. PEA formation can be explained by the 1,5-cyclization of a transient compound giving a 1,3,2-oxazaphospholidine intermediate whose P-N bond is exclusively cleaved in acidic medium. The presence of monohydroxyIPM (monoOHIPM) (whose percentage increases with pH from 5% (pH 3.5) to approximate to 28% (pH 5.0) of all the IPM phosphorylated degradation compounds), probably coming from the alkylation by water of an aziridine/aziridinium intermediate, demonstrates the occurrence of pathway II. At pH 7.0 and 7.4, the pathway II is initiated first, leading to 1,3-cyclization(s), followed by water alkylation of the aziridines formed. The sequences are IPM 1 --> monoAzIPM 5 --> bisAzIPM 9; IPM 1 --> monoAzIPM 5 --> monoOHIPM 6 --> monoAzIPM with a N-hydroxyethylchain (presumed structure) 7 --> dihydroxyIPM 8. Nevertheless, PEA and Pi are the final products observed, which implies the P-N bond hydrolysis of products 5-9 as demonstrated by the presence in the medium of CEA, aziridine and ethanolamine. (C) 2001 Elsevier Science B.V. Al rights reserved.
引用
收藏
页码:669 / 678
页数:10
相关论文
共 21 条
[1]   P-31-NMR STUDIES OF THE KINETICS OF BISALKYLATION BY ISOPHOSPHORAMIDE MUSTARD - COMPARISONS WITH PHOSPHORAMIDE MUSTARD [J].
BOAL, JH ;
WILLIAMSON, M ;
BOYD, VL ;
LUDEMAN, SM ;
EGAN, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1768-1773
[2]  
BOLTON MG, 1993, DRUG METAB DISPOS, V21, P986
[3]  
BREIL S, 2000, P AM ASSOC CANC RES, V41, P426
[4]  
COLVIN M, 1976, CANCER RES, V36, P1121
[5]   GLUTATHIONE CONJUGATION OF THE CYTOSTATIC DRUG IFOSFAMIDE AND THE ROLE OF HUMAN GLUTATHIONE S-TRANSFERASES [J].
DIRVEN, HAAM ;
MEGENS, L ;
OUDSHOORN, MJ ;
DINGEMANSE, MA ;
VANOMMEN, B ;
VANBLADEREN, PJ .
CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (07) :979-986
[6]   THE INTERACTION OF GLUTATHIONE WITH 4-HYDROXYCYCLOPHOSPHAMIDE AND PHOSPHORAMIDE MUSTARD, STUDIED BY P-31 NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY [J].
DIRVEN, HAAM ;
VENEKAMP, JC ;
VANOMMEN, B ;
VANBLADEREN, PJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1994, 93 (03) :185-196
[7]   P-31 NMR INVESTIGATIONS OF PHOSPHORAMIDE MUSTARD - EVALUATION OF PH CONTROL OVER THE RATE OF INTRA-MOLECULAR CYCLIZATION TO AN AZIRIDINIUM ION AND THE HYDROLYSIS OF THIS REACTIVE ALKYLATOR [J].
ENGLE, TW ;
ZON, G ;
EGAN, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (08) :897-898
[8]   P-31 NMR KINETIC-STUDIES OF THE INTRAMOLECULAR AND INTERMOLECULAR ALKYLATION CHEMISTRY OF PHOSPHORAMIDE MUSTARD AND COGNATE N-PHOSPHORYLATED DERIVATIVES OF N,N-BIS(2-CHLOROETHYL)AMINE [J].
ENGLE, TW ;
ZON, G ;
EGAN, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (11) :1347-1357
[9]   P-31 NMR AND CHLORIDE-ION KINETICS OF ALKYLATING MONOESTER PHOSPHORAMIDATES [J].
FRIES, KM ;
BORCH, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :565-569
[10]   EFFECTS OF N-SUBSTITUTION ON THE ACTIVATION MECHANISMS OF 4-HYDROXYCYCLOPHOSPHAMIDE ANALOGS [J].
KWON, CH ;
BORCH, RF .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) :1491-1496